URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://beyondspringpharma.com/beyondspring-enrolls-first-patient-in-phase-2-study-with-plinabulin-keytruda-and-docetaxel-in-patients-with-metastatic-non-small-cell-lung-cancer-who-progressed-after-immunotherapy/ | 20% | Monthly | 2023-03-01 15:13 |